After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Earlier, Yahoo Finance discussed this stock as it revealed Clover Health Launches New Clinical Program in Partnership with Quartet Health to Address Serious Mental Illness.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
This NASDAQ-listed company operates within the Healthcare Plans industry segment, falling under the Healthcare sector. At the end of the last regular session, the stock closed at $0.88 and fluctuated between $0.8897 as its day high and $0.8216 as its day low. The current market capitalization of Clover Health Investments Corp is $435.28M. A total of 12.24 million shares were traded on the day, compared to an average of 9.59M shares.
In the most recent transaction, Loengard Anna U bought 137,000 shares of CLOV for 0.73 per share on Mar 14 ’24. After the transaction, the Director now owns 538,841 company shares. In a previous transaction on Mar 14 ’24, Loengard Anna U bought 13,625 shares at 0.73 per share. CLOV shares that Director owns now total 15,125.
Among the insiders who bought shares, Loengard Anna U acquired of 11,000 shares on Sep 06 ’23 at a per-share price of $1.30. This resulted in the Director holding 10,000 shares of CLOV after the transaction.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, CLOV has a high of $1.63 and a low of $0.71.
As of this writing, CLOV has an earnings estimate of -$0.07 per share for the current quarter. EPS was calculated based on a consensus of 2 estimates, with a high estimate of -$0.06 per share and a lower estimate of -$0.09. The company reported an EPS of -$0.09 in the last quarter, which was 18.20% higher than expectations of -$0.11.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. CLOV’s latest balance sheet shows that the firm has $615.25M in Cash & Short Term Investments as of fiscal 2021. There were $27.83M in debt and $372.62M in liabilities at the time. Its Book Value Per Share was $0.60, while its Total Shareholder’s Equity was $539.32M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CLOV is Buy with a score of 3.67.
